SCHEMBL4255132

SCHEMBL4255132

CCC(=Cc1ccc(C(=C2CCCCCC2)c2ccc(O)c(Cl)c2)cc1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.39
ESR2 Q92731 4/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
TBXAS1 P24557 2/20 0.38
PGR P06401 1/20 0.36
CHRM2 P08172 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
AR P10275 1/20 0.36
CHRM1 P11229 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
EPHX2 P34913 1/20 0.36
PPARG P37231 1/20 0.36
RARA P10276 1/20 0.34
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4257163 1.00 ESR1 (0.39) ESR1ESR2HSP90AA1HSP90AB1OPRM1
SCHEMBL4258010 0.89 ESR1 (0.41) ESR1ESR2TBXAS1PGRCHRM2
SCHEMBL4253238 0.87 ESR1 (0.39) ESR1ESR2OPRM1OPRD1TBXAS1
SCHEMBL4255146 0.84 HSP90AA1 (0.37) ESR1ESR2HSP90AA1HSP90AB1OPRM1
SCHEMBL4252411 0.83 HSP90AA1 (0.36) ESR1HSP90AA1HSP90AB1OPRM1OPRD1
SCHEMBL4257160 0.81 HSP90AA1 (0.41) ESR1ESR2HSP90AA1HSP90AB1OPRM1
SCHEMBL4255125 0.81 HSP90AA1 (0.41) ESR1ESR2HSP90AA1HSP90AB1OPRM1
SCHEMBL4261809 0.80 TBXAS1 (0.38) ESR1ESR2TBXAS1PGRCHRM2
SCHEMBL4258694 0.80 EPHX2 (0.37) ESR1ESR2OPRM1OPRD1OPRK1
SCHEMBL4254775 0.79 ESR1 (0.42) ESR1ESR2HSP90AB1OPRM1TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569601-B2 Cycloalkylidene compounds as modulators of estrogen receptor SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
US-20070213348-A1 Chemical Compounds BRITTON JONATHAN E 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213348-A1 Chemical Compounds GPER1, ESR2, ESR1 ESR1 3/4885ESR2 2/4885HSP90AA1 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.